[Skip to Navigation]
Comment & Response
September 2017

The Statistical Significance of the Efficacy Results in a Randomized Clinical Trial—Reply

Author Affiliations
  • 1Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece
JAMA Dermatol. 2017;153(9):950. doi:10.1001/jamadermatol.2017.3244

In Reply On behalf of my coauthors, I am writing to reply to a reader’s query regarding the statistics of the primary efficacy end point in our article, “Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial,”1 published online on November 18, 2015, and in the January 2016 issue of JAMA Dermatology. We are grateful to Dr Su for his inquiry.

Add or change institution